{"id":"2ce2a2f6-100c-4bbb-bab1-7e958f864d9b","modelId":"e09e4e3e-bb57-42b8-abb9-ecee81463743","versionId":null,"locationId":"6f0df9a2-cf63-43c7-8f07-0c0aaaf88652","operatorId":"1942437f-dbb8-4059-9dcb-6b87817b7950","ownerId":null,"slug":"wandercraft-personal-clinical-trial","status":"operational","firstSeen":"2024-01-01T00:00:00.000Z","statusChangeReason":null,"contractType":null,"pilotOutcome":null,"endedAt":null,"unitsOnSite":null,"tasksPerformed":["autonomous_operation"],"shiftStructure":null,"hoursPerDay":8,"siteType":"hospital","operatorConfirmed":null,"humanSupervisionOnsite":null,"locationPrecisionTier":"verified_coordinates","deploymentScale":"clinical","siteEnvironment":"clinical","operatorType":"maker_operated","sourceQualityTier":2,"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://en.wandercraft.eu/","title":"Personal Exoskeleton - Wandercraft","source":"Wandercraft","dateAccessed":"2026-08-08"}],"notes":"Wandercraft Personal Exoskeleton — first self-balancing personal exoskeleton that doesn't require crutches. Clinical trials launched in the United States. FDA-cleared Atalante X for rehab centers in Europe, US, and Brazil.","keyFacts":[{"date":"2024-01-01","fact":"First self-balancing personal exoskeleton (no crutches)"},{"date":"2023-01-01","fact":"FDA-cleared Atalante X for rehab in EU/US/Brazil"},{"date":"2024-01-01","fact":"US clinical trials for Personal Exoskeleton launched"}],"reviewNote":null,"exposureHours":null,"deploymentMilesEstimate":null,"exposureBasis":null,"customerSegment":"healthcare","scaleTier":"commercial_10_99","contractValueUsd":null,"contractValueBasis":null,"customerCompanyId":null,"customerExternalName":null,"createdAt":"2026-08-08T23:40:38.010Z","updatedAt":"2026-08-21T17:11:22.954Z","model":{"id":"e09e4e3e-bb57-42b8-abb9-ecee81463743","companyId":"1942437f-dbb8-4059-9dcb-6b87817b7950","modelName":"Wandercraft Atalante X","slug":"wandercraft-atalante-x","description":"Powered, self-balancing full-body lower-limb exoskeleton that walks HANDS-FREE (no crutches) using AI-driven dynamic balance across ~12 actuated degrees of freedom. The autonomy is real-time balance/gait control; clinician sets the session. FDA cleared early 2024, indications expanded 2025 (MS, C4-L5 SCI). Deployed in 100+ rehab/research facilities.","formFactor":"exoskeleton","industryVertical":null,"environment":null,"maturityStage":"commercial","lifecycleState":"active","supersededByModelId":null,"specs":{"use":"medical rehab","control":"AI-driven autonomous dynamic balance (hands-free, no crutches)","powered":"yes (12 actuated DOF)","regulatory":"FDA cleared 2024, expanded 2025","body_region":"full-body lower-limb","availability":"commercial (100+ facilities)"},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://www.massdevice.com/fda-expands-indications-wandercraft-atalante-exoskeleton/","title":"Wandercraft Atalante X","sourceName":"MassDevice"},{"url":"https://en.wikipedia.org/wiki/Wandercraft","title":"Wandercraft","sourceName":"Wikipedia"}],"aliases":["Atalante X","Atalante"],"collisionRisk":"low","reviewNote":"reverified 2026-06-09 (Kimi-incident remediation): cited primary source resolves and matches manufacturer/reputable domain; relevance adjudicated.","manufacturerTermForTeleop":null,"keyFacts":[{"label":"Robot","value":"Atalante is a self-balancing, hands-free walking exoskeleton that requires no crutches."},{"label":"Technology","value":"Uses AI-driven dynamic balance for walking."},{"label":"Company type","value":"French powered-exoskeleton maker"}],"createdAt":"2026-06-06T01:25:40.922Z","updatedAt":"2026-07-08T20:02:15.945Z","unitsInFieldClaimed":null,"unitsInFieldVerified":null,"unitsManufacturedClaimed":null,"unitsManufacturedVerified":null,"unitsAsOf":null,"unitsSource":null,"salesModel":null,"priceUndisclosedSince":null,"autonomyClass":null,"autonomyStatement":null,"autonomyStatementSource":null,"demoForensics":null,"exportControlClass":null,"minCommitment":null,"warrantyTerms":null,"serviceModel":null,"productionRateClaimed":null,"productionRateEvidenced":null,"teleopRatioDisclosed":null,"interventionRateDisclosed":null,"company":{"id":"1942437f-dbb8-4059-9dcb-6b87817b7950","name":"Wandercraft","slug":"wandercraft","description":"Wandercraft is a French robotics maker (founded 2012, Paris) that builds self-balancing walking machines. Its original line is medical: the Atalante X rehabilitation [exoskeleton](/companies/exoskeleton-technologies), FDA cleared in 2024 and deployed in 100+ rehab and research facilities, and Eve, the personal-use version cleared by the FDA in August 2026. In 2025 the company applied the same dynamic-balance control stack to industry and built [Calvin-40](/models/wandercraft-calvin-40), a headless industrial humanoid, co-developed with [Renault Group](/companies/renault-group), which took a minority stake in June 2025 and is the first commercial customer.","status":"private","founded":2012,"hq":"Paris, France","hqLat":48.8534951,"hqLng":2.3483915,"hqGeocodedAt":"2026-08-05T14:54:34.836Z","hqAddress":null,"hqPrecision":null,"website":"wandercraft.eu","fundingTotal":"120000000","type":"hardware","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","heatIndex":77,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://www.massdevice.com/fda-expands-indications-wandercraft-atalante-exoskeleton/","title":"Wandercraft","sourceName":"MassDevice"},{"url":"https://en.wikipedia.org/wiki/Wandercraft","title":"Wandercraft","sourceName":"Wikipedia"},{"url":"https://www.wandercraft.eu/calvin","label":"Calvin-40","title":"Calvin-40","mediaType":"article","sourceName":"Wandercraft"},{"url":"https://www.globenewswire.com/news-release/2025/06/11/3097632/0/en/Wandercraft-announces-Series-D-Round-bringing-75M-in-total-funding-secured-for-global-acceleration-of-AI-powered-robotics.html","label":"Wandercraft announces Series D Round, bringing $75M in total funding secured","title":"Wandercraft announces Series D Round, bringing $75M in total funding secured","mediaType":"article","sourceName":"GlobeNewswire"}],"keyFacts":[{"label":"Two product lines","value":"Medical exoskeletons (Atalante X, Eve) and an industrial humanoid (Calvin-40)."},{"label":"Shared technology","value":"Both lines run the same self-balancing dynamic-gait control stack, developed over 12 years of exoskeleton work."},{"label":"Calvin-40 anchor customer","value":"Renault Group: one trial unit at the Douai plant, with a stated roadmap of about 10 robots by end 2026 and 350 across French and Spanish plants by end 2027."},{"label":"Company type","value":"French self-balancing robotics maker, Paris"}],"aliases":["Wandercraft SAS","Wandercraft S.A.S."],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-06-06T01:25:37.962Z","updatedAt":"2026-09-15T04:18:09.500Z"}},"version":null,"location":{"id":"6f0df9a2-cf63-43c7-8f07-0c0aaaf88652","name":"New York, USA","slug":"new-york-usa","kind":"city","parentLocationId":null,"region":"Northeast","lat":40.71,"lng":-74.01,"reviewStatus":"reviewed","aliases":[],"collisionRisk":"high","reviewNote":"Anchoring deployment: Wandercraft Atalante X and Eve self-balancing exoskeletons in clinical trials at James J. Peters VA Medical Center (Bronx), Kessler Institute, and Walk in New York NYC. FDA cleared Eve personal exoskeleton Aug 2026. Early mobilization ICU trial at Brigham and Women's (Mass General Brigham). Multiple NYC-area rehabilitation sites. Source: wandercraft.eu.","createdAt":"2026-08-08T23:40:37.238Z","updatedAt":"2026-08-12T16:07:30.935Z"},"operator":{"id":"1942437f-dbb8-4059-9dcb-6b87817b7950","name":"Wandercraft","slug":"wandercraft","description":"Wandercraft is a French robotics maker (founded 2012, Paris) that builds self-balancing walking machines. Its original line is medical: the Atalante X rehabilitation [exoskeleton](/companies/exoskeleton-technologies), FDA cleared in 2024 and deployed in 100+ rehab and research facilities, and Eve, the personal-use version cleared by the FDA in August 2026. In 2025 the company applied the same dynamic-balance control stack to industry and built [Calvin-40](/models/wandercraft-calvin-40), a headless industrial humanoid, co-developed with [Renault Group](/companies/renault-group), which took a minority stake in June 2025 and is the first commercial customer.","status":"private","founded":2012,"hq":"Paris, France","hqLat":48.8534951,"hqLng":2.3483915,"hqGeocodedAt":"2026-08-05T14:54:34.836Z","hqAddress":null,"hqPrecision":null,"website":"wandercraft.eu","fundingTotal":"120000000","type":"hardware","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","heatIndex":77,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://www.massdevice.com/fda-expands-indications-wandercraft-atalante-exoskeleton/","title":"Wandercraft","sourceName":"MassDevice"},{"url":"https://en.wikipedia.org/wiki/Wandercraft","title":"Wandercraft","sourceName":"Wikipedia"},{"url":"https://www.wandercraft.eu/calvin","label":"Calvin-40","title":"Calvin-40","mediaType":"article","sourceName":"Wandercraft"},{"url":"https://www.globenewswire.com/news-release/2025/06/11/3097632/0/en/Wandercraft-announces-Series-D-Round-bringing-75M-in-total-funding-secured-for-global-acceleration-of-AI-powered-robotics.html","label":"Wandercraft announces Series D Round, bringing $75M in total funding secured","title":"Wandercraft announces Series D Round, bringing $75M in total funding secured","mediaType":"article","sourceName":"GlobeNewswire"}],"keyFacts":[{"label":"Two product lines","value":"Medical exoskeletons (Atalante X, Eve) and an industrial humanoid (Calvin-40)."},{"label":"Shared technology","value":"Both lines run the same self-balancing dynamic-gait control stack, developed over 12 years of exoskeleton work."},{"label":"Calvin-40 anchor customer","value":"Renault Group: one trial unit at the Douai plant, with a stated roadmap of about 10 robots by end 2026 and 350 across French and Spanish plants by end 2027."},{"label":"Company type","value":"French self-balancing robotics maker, Paris"}],"aliases":["Wandercraft SAS","Wandercraft S.A.S."],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-06-06T01:25:37.962Z","updatedAt":"2026-09-15T04:18:09.500Z"},"owner":null,"derived":{"trustTier":"unverified","currentPosture":null},"jsonLd":{"@context":"https://schema.org","@type":"Event","@id":"https://registry.deploy.report/deployments/wandercraft-personal-clinical-trial","url":"https://registry.deploy.report/deployments/wandercraft-personal-clinical-trial","name":"Wandercraft Atalante X at New York, USA","identifier":"2ce2a2f6-100c-4bbb-bab1-7e958f864d9b","startDate":"2024-01-01T00:00:00.000Z","location":{"@type":"Place","@id":"https://registry.deploy.report/locations/new-york-usa","name":"New York, USA"},"organizer":{"@type":"Organization","@id":"https://registry.deploy.report/companies/wandercraft","name":"Wandercraft"},"about":{"@type":"Product","@id":"https://registry.deploy.report/models/wandercraft-atalante-x","name":"Wandercraft Atalante X"},"publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":"commercial","lifecycle_state":"active","architectural_position":{"cohort":"exoskeleton","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":1,"primary_source_types":[]}}}